Molecular Microbiology Lab @IiserTirupati #TB #Mycomembrane #Antibiotic_tolerance We employ TnSeq & LC-MS proteomics to unravel mycobacterial mysteries
IISER Tirupati, India
Joined October 2020
- Tweets100
- Following221
- Followers220
- Likes117
Raju Mukherjee's Lab retweeted
Methylglyoxal is an antibacterial effector produced by macrophages during infection | bioRxiv biorxiv.org/content/10.1101/…
Raju Mukherjee's Lab retweeted
Tuberculosis resurges as top infectious disease killer who.int/news/item/29-10-2024…
Raju Mukherjee's Lab retweeted
Multidrug tolerance conferred by loss-of-function mutations in anti-sigma factor RshA of Mycobacterium abscessus journals.asm.org/doi/10.1128…
We are excited to organise this EMBO Satellite Symposia on "Infection Biology at IISER Tirupati, India. Prolific speakers will share and discuss great science happening at the frontiers of infection biology!
Pls join us, register and RT!
@IiserTirupati @EMBO @CNRS
Raju Mukherjee's Lab retweeted
Drug-resistant #TB continues to challenge global health systems. By investing in innovative research and development, we can ensure no one is left behind. #EndTB #AMRAction
Raju Mukherjee's Lab retweeted
Excited to share our last work regarding the characterization of a dTDP-L-Rhamnose 4-epimerase required for glycopeptidolipid biosynthesis in mycobacteria. Thanks to the @GuerardelY, @WilmannsGroup, @jl_herrmann, @canaanLab, K Nakajima and L Wen teams.
jbc.org/article/S0021-9258(2…
Excited to share Tejan's @TejanL PhD thesis work published in @eLife doi.org/10.7554/eLife.99656.…
Grateful to @IiserTirupati @CSIR_IND @DBTIndia @EMBO for funding.
Fun working with @AseemPalande @gLarrouyM_Lab @danybeste
Great collaboration & pleasure working with @danybeste Pls RT!
Raju Mukherjee's Lab retweeted
A new axis of pathogenicity in #tuberculosis involving #neutrophils and a strategy to improve TB prevention and control!
@ICGEBNewDelhi @DBTIndia @Lab_AmitSinghal
doi.org/10.7554/eLife.100966 @eLife
Raju Mukherjee's Lab retweeted
After years of complacency, the world is waking up to TB's deadly toll. A new vaccine could prevent millions of cases and save countless lives. Find out more in an article from @Telegraph telegraph.co.uk/global-healt… #EndTB #GlobalHealth
Raju Mukherjee's Lab retweeted
AMR is being highlighted at the UN General Assembly. We know how devastating drug resistant infections can be for individuals and communities. 👇theguardian.com/global-devel…
Raju Mukherjee's Lab retweeted
⚠️ Happy to share our latest preprint on the pH dependent activity of salicylic acid derivatives against M.tuberculosis 🦠🧫🔬🤓
Very cool team work with the one and only @JefCavalier @canaanlab @LISM_CNRS_AMU & @ULBruxelles 👇👇👇
Anti-tubercular potential and pH-driven mode of action of salicylic acid derivatives biorxiv.org/cgi/content/shor… #biorxiv_micrbio
Our lab has an opening for a postdoc position on understanding antibiotic tolerance in M. tuberculosis
Info & Apply @ iisertirupati.ac.in/wp-conte…
Pls reach out to [email protected] for more information
For Indian nationals only
Raju Mukherjee's Lab retweeted
Few additions:
- Only student/trainie registration (INR 12,000) include sharing basis accomodation 🙂.
- Travel and Child care grants from @EMBO
- Flights from many major destinatins in Asia, EU, and US. Best connection by SQ, AirFrance and Emirates.
Official poster out 🤩 @EMBO #TB Host and Pathogen #Heterogenity #Hyderabad #India @ccmb_csir
@idlabs_astar @PriscilleBrodin @EmboMolMed @ICGEBNewDelhi
- 25 Invited speakers
- 50 Abstracts - Flash talk
- 12 Abstracts - Short talk
- Travel grants
- Reg. fee include accomodation
Raju Mukherjee's Lab retweeted
NTM conference @ Colorado State Is happening again in 2025! Topics range from basic research on host and bacteria to diagnosis and therapy. Yes, phage therapy included. Registration opens Dec. 1 search.app/dXGDMakTu4K2MszB8
Raju Mukherjee's Lab retweeted
India is getting ready to roll out BPaL regimen for all M/XDRTB patients - training to begin this month. This should improve treatment outcomes & help thousands of patients. Scaling up NAAT coverage will be an essential element of the strategy @WHO @StopTB @TBHDJ @MoHFW_INDIA
Turns out we can save lives and money. When countries use the short, all-oral regimens to treat people with drug-resistant #tuberculosis, they save between 15-60%: ncbi.nlm.nih.gov/pmc/article… #endTB #6MonthsMax
JOB ALERT: We have two 1-year postdoc positions open. Work will involve culturing & manipulating Mtb, cell culture, and mass spectrometry based metabolomics in our brand new BSL-3. Interested applicants can send can send their CV to [email protected]
Pls RT.
Raju Mukherjee's Lab retweeted
Poor nutrition and lack of stimulation leads to poor brain growth & development in childhood & future incomes reduced by 25%. That’s why it’s so critical to invest in the first 1000 days of life. @MinistryWCD @MoHFW_INDIA @ICMRDELHI @NITIAayog @AnuraKurpad @MSuzman
Raju Mukherjee's Lab retweeted
After a gap of 4 years, the EMBO TB meeting returns, this time @ccmb_csir Hyderabad. Feb, 9-12, 2025 #Tuberculosis #heterogeneity #drugs #hostpathogeninteraction @ICGEBNewDelhi @DBTIndia @Lab_AmitSinghal @PriscilleBrodin
meetings.embo.org/event/25-t…
Proud moment for the lab! The first two PhD students @Saniya_IISERTPT & @TejanL and one BSMS student @Souparnika_088 graduated this year from the lab! Very proud of their training, skills, achievements and contributions to our budding lab!
@TejanL developed LC-MS/MS based quantitative proteomics methodology using Orbitrap mass spectrometry, which continues to serve as a great resource for the lab & collaborative projects.
Being the second PhD student of the lab @TejanL utilised proteomics to identify secondary mechanisms of existing antibiotics as well as early adaptive mechanisms utilised by mycobacteria - biorxiv.org/content/10.1101/…
